Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study

Cannabinoid 1 receptor and glutamatergic dysfunction have both been implicated in the pathophysiology of schizophrenia. However, it remains unclear if cannabinoid 1 receptor alterations shown in drug-naïve/free patients with first episode psychosis may be linked to glutamatergic alterations in the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgan, Faith, Veronese, Mattia, Reis Marques, Tiago, Lythgoe, David J., Howes, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119269/
https://www.ncbi.nlm.nih.gov/pubmed/32986150
http://dx.doi.org/10.1007/s00406-020-01191-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119269/
https://www.ncbi.nlm.nih.gov/pubmed/32986150
http://dx.doi.org/10.1007/s00406-020-01191-2

Ejemplares similares